Panacea Biotec reports consolidated net profit of Rs 15.70 crore in the September 2022 quarter
Sales decline 54.72% to Rs 105.12 crore
Net profit of Panacea Biotec reported to Rs 15.70 crore in the quarter ended September 2022 as against net loss of Rs 53.01 crore during the previous quarter ended September 2021. Sales declined 54.72% to Rs 105.12 crore in the quarter ended September 2022 as against Rs 232.17 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales105.12232.17 -55 OPM %-3.652.59 -PBDT5.43-42.11 LP PBT-4.46-53.01 92 NP15.70-53.01 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content